PhaseBio Pharmaceuticals, Inc. filed a notice of extension of certain bidding dates in the US Bankruptcy Court on December 22, 2022. As per the notice filed, with respect to Non-Bentracimab Assets, the bidding deadline has been extended to January 6, 2023, auction is scheduled on January 17, 2023. The sale heading shall occur on January 30, 2023 and sale closing shall occur on or prior to February 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 49 | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PHAS.Q Stock
- News PhaseBio Pharmaceuticals, Inc.
- Notice of Extention of Bidding Procedures Deadlines Filed by PhaseBio Pharmaceuticals, Inc.